OUR RESOURCES

HRD Is The New BRCA

Welcome & Introduction

The Importance of Early Diagnosis & Surgical management of Ovarian cancer

Strand HRD Test

Clinical Updates in the Management of early Breast Cancer

Welcome & Introduction

Localization Techniques for Impalpable Breast Lesions

BCS vs MRM Post NACT

Hepatocellular Carcinoma Update

Welcome & Introduction

Epidemiology and diagnosis of HCC

Screening and Surveillance of HCC

New Paradigms in Lung Cancer Management

Welcome & Introduction

Importance of molecular testing in treating Lung cancer

Newer Paradigms in the Treatment of Resected EGFRm Early Lung Cancer

Management of Genitourinary Cancer Revisit ASCO

Welcome & Introduction

NAT IN MIBC IDEAL DRUG REGIMEN

IMbrave 150 Phase III trial of 1L Atezolizumab + Bevacizumab in patients with unresectable HCC